Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.
ClinicalTrials.gov study NCT06033287. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
ClinicalTrials.gov study NCT03960840. IPD Sharing: NO. Countries: 8. Publications: 0.
HVA vs IA/DA or VA in the Treatment of ND HR-AML
ClinicalTrials.gov study NCT06810791. IPD Sharing: NO. Countries: 1. Publications: 0.
Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT06394661. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.
ClinicalTrials.gov study NCT04733417. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
ClinicalTrials.gov study NCT06486883. IPD Sharing: NO. Countries: 3. Publications: 0.
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
ClinicalTrials.gov study NCT06148506. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer
ClinicalTrials.gov study NCT06343948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
ClinicalTrials.gov study NCT05718622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
ClinicalTrials.gov study NCT01814865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
ClinicalTrials.gov study NCT07384715. IPD Sharing: NO. Countries: 0. Publications: 0.
Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC
ClinicalTrials.gov study NCT05343117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure
ClinicalTrials.gov study NCT05335473. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
ClinicalTrials.gov study NCT06942039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer
ClinicalTrials.gov study NCT06389006. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
ClinicalTrials.gov study NCT07117630. IPD Sharing: NO. Countries: 1. Publications: 0.
Doppler Ultrasound Compared With Stethoscope to Assess Heart Rate (HR)
ClinicalTrials.gov study NCT04242654. IPD Sharing: NO. Countries: 1. Publications: 0.
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT06388122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
ClinicalTrials.gov study NCT06977893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
ClinicalTrials.gov study NCT06738966. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.